According to Co-Diagnostics
's latest financial reports the company has a price-to-book ratio of 0.4579.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.4729 | -30.5% |
2022-12-31 | 0.6803 | -64.87% |
2021-12-31 | 1.94 | -51.37% |
2020-12-31 | 3.98 | -55.44% |
2019-12-31 | 8.94 | -149.14% |
2018-12-31 | -18.2 | -315.95% |
2017-12-31 | 8.42 | |
2016-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
PAVmed
PAVM | -0.8914 | -294.67% | ๐บ๐ธ USA |
Philips PHG | 1.80 | 293.52% | ๐ณ๐ฑ Netherlands |